[Skip to content]

Print this page

Latest news

Derby patients benefit from advanced radiotherapy treatments

Published 06/11/2013

More than 50% of Derby Hospitals’ cancer patients are benefitting from an advanced type of radiotherapy which reduces side-effects associated with standard cancer treatments.
Patients with prostate cancer are so far the largest users of inverse-planned IMRT (Intensity Modulated Radiotherapy) because the treatment can be targeted very precisely to avoid side-effects to the bladder and bowel.

The Inverse-planned IMRT treatment matches the shape of the tumour being treated, using a mosaic effect to ensure that very high doses of radiation can be targeted to the correct area, while minimising the damage done to surrounding healthy tissues.
The Prime Minister has pledged to improve access to advanced and innovative radiotherapy treatments for patients across England. Derby Hospitals secured £500,000 from the Government’s Cancer Radiotherapy Innovation Fund to procure specialist equipment that would improve access to inverse-planned IMRT.

Wendy Steele, Radiotherapy Manager at Derby Hospitals, said: “Thanks to the funding and all the hard work put in by our dedicated staff we have been able to achieve the national target set by the Government, which requires 24% of patients receiving curative radiotherapy to be given inverse-planned IMRT.

“Our work is not over and we will continue to invest in improving radiotherapy treatments and innovations for our patients. IMRT has been very beneficial to patients because they experience fewer side effects. Patients with prostate cancer are the largest group to benefit from this specialist treatment because the high doses of radiation can be targeted very precisely to avoid side-effects to the bladder and bowel.”
For further information, please contact:

Amanda Wells
Communications and Media Manager
Derby Hospitals NHS Foundation Trust
01332 786947
07799 337677

Last Modified 06/11/2013